FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3029262857> ?p ?o ?g. }

• W3029262857 endingPage "318" @default.
• W3029262857 startingPage "313" @default.
• W3029262857 abstract "Objective To evaluate the safety and efficacy of patient controlled analgesia effect-site target controlled infusion (PCA-TCI) of sufentanil in elderly patients after transurethral resection of benign prostatic hyperplasia (TURP). Methods Sixty elderly patients (ASA Ⅰ - Ⅱ ) scheduled for TURP were randomized into four groups (n=15 each). PCA-TCI was used in the first three groups with the same analgesic dosage (1 mg/L sufentanil) but different initial target plasma concentrations (Cp) (0.06 μg/L in group Ⅰ ,0.08 μg/L in group Ⅱ and 0.10 μg/L in group Ⅲ ) and minimum effective Cp (0.04 μg/L in group Ⅰ , 0.05μg/L in groups Ⅱ and Ⅲ ). The group Ⅳ was set as control group, using patient controlled epidural analgesia (PECA) with 0.06 mg/L morphine + 0.2％ ropivacaine+0.9％ normal saline under losding+continous+PCA (LCP) mode. After the operation, the analgesia device was switched on when the level of sensory blockade receded to T10. Before and at different time points after the start of analgesia, visual analogue score (VAS),Ramsay sedation score, modified Bromage score, plasma target concentration (Cp) of sufentanil, systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), blood oxygen saturation (SpO2),respiratory rate (RR) and patient satisfaction with analgesia were assessed. Moreover, number of patient-pressed bolus (D1) and of bolus delivered (D2) , the time to pass gas and adverse reactions were recorded.Results All the patients in the four groups were satisfied with the PCA device. At any given time points,there were no significant differences in Ramsay score among the 4 groups (P＞0.05), VAS and D1/D2 among groups Ⅱ, Ⅲ and Ⅳ (P＞0.05), whereas the VAS score in group Ⅰ was higher at 1, 2 and 4 hours (P＜0.05)compared to groups Ⅱ and Ⅲ. All the patients passed gas within 24 h, but the time to gas-passing was longer in group Ⅳ (19.1±2.5)h compared with group Ⅰ (16.5±3.9)h, group Ⅱ (16.2±3.8)h and groupⅢ (16.8±4.1 )h (P＜0.05). The total sufentanil use was similar in groups Ⅰ and Ⅱ[(36.7±5.1)μg vs (37.8±4.7)μg,P＞0.05], and was the highest in group Ⅲ (42.3±5.6) μg (P＜0.05). There was no significant difference in adverse reactions among the four groups. Conclusions PCA- TCI of sufentanil in elderly patients for postoperative analgesia after TURP is effective and safe. Configurations of sufentanil analgesia with initial target plasma concentration being 0.08 μg/L and minimum effective concentration being 0.05 μg/L may result in lowest VAS and reduced dosage, which is favorable for stable blood circulation among the patients.Key words: Sufentanil; Analgesia; Transurethral resection of prostate; Target-controlled infusion; Patient-controlled" @default.
• W3029262857 created "2020-06-05" @default.
• W3029262857 creator A5011029076 @default.
• W3029262857 creator A5017860702 @default.
• W3029262857 creator A5017965616 @default.
• W3029262857 creator A5042906464 @default.
• W3029262857 date "2011-08-15" @default.
• W3029262857 modified "2023-09-25" @default.
• W3029262857 title "Safety and efficacy of patient controlled analgesia effect-site target controlled infusion of sufentanll in elderly patients after transurethral resection of the prostate" @default.
• W3029262857 doi "https://doi.org/10.3760/cma.j.issn.1674-1927.2011.04.005" @default.
• W3029262857 hasPublicationYear "2011" @default.
• W3029262857 type Work @default.
• W3029262857 sameAs 3029262857 @default.
• W3029262857 citedByCount "0" @default.
• W3029262857 crossrefType "journal-article" @default.
• W3029262857 hasAuthorship W3029262857A5011029076 @default.
• W3029262857 hasAuthorship W3029262857A5017860702 @default.
• W3029262857 hasAuthorship W3029262857A5017965616 @default.
• W3029262857 hasAuthorship W3029262857A5042906464 @default.
• W3029262857 hasConcept C121608353 @default.
• W3029262857 hasConcept C126322002 @default.
• W3029262857 hasConcept C141071460 @default.
• W3029262857 hasConcept C197934379 @default.
• W3029262857 hasConcept C2776045914 @default.
• W3029262857 hasConcept C2776235491 @default.
• W3029262857 hasConcept C2776814716 @default.
• W3029262857 hasConcept C2777019824 @default.
• W3029262857 hasConcept C2777397205 @default.
• W3029262857 hasConcept C2777953023 @default.
• W3029262857 hasConcept C2780269707 @default.
• W3029262857 hasConcept C2780768273 @default.
• W3029262857 hasConcept C2780820201 @default.
• W3029262857 hasConcept C42219234 @default.
• W3029262857 hasConcept C43376680 @default.
• W3029262857 hasConcept C71924100 @default.
• W3029262857 hasConcept C8213797 @default.
• W3029262857 hasConcept C84393581 @default.
• W3029262857 hasConceptScore W3029262857C121608353 @default.
• W3029262857 hasConceptScore W3029262857C126322002 @default.
• W3029262857 hasConceptScore W3029262857C141071460 @default.
• W3029262857 hasConceptScore W3029262857C197934379 @default.
• W3029262857 hasConceptScore W3029262857C2776045914 @default.
• W3029262857 hasConceptScore W3029262857C2776235491 @default.
• W3029262857 hasConceptScore W3029262857C2776814716 @default.
• W3029262857 hasConceptScore W3029262857C2777019824 @default.
• W3029262857 hasConceptScore W3029262857C2777397205 @default.
• W3029262857 hasConceptScore W3029262857C2777953023 @default.
• W3029262857 hasConceptScore W3029262857C2780269707 @default.
• W3029262857 hasConceptScore W3029262857C2780768273 @default.
• W3029262857 hasConceptScore W3029262857C2780820201 @default.
• W3029262857 hasConceptScore W3029262857C42219234 @default.
• W3029262857 hasConceptScore W3029262857C43376680 @default.
• W3029262857 hasConceptScore W3029262857C71924100 @default.
• W3029262857 hasConceptScore W3029262857C8213797 @default.
• W3029262857 hasConceptScore W3029262857C84393581 @default.
• W3029262857 hasIssue "04" @default.
• W3029262857 hasLocation W30292628571 @default.
• W3029262857 hasOpenAccess W3029262857 @default.
• W3029262857 hasPrimaryLocation W30292628571 @default.
• W3029262857 hasRelatedWork W2349331476 @default.
• W3029262857 hasRelatedWork W2351658240 @default.
• W3029262857 hasRelatedWork W2364611216 @default.
• W3029262857 hasRelatedWork W2365177342 @default.
• W3029262857 hasRelatedWork W2365337246 @default.
• W3029262857 hasRelatedWork W2368572890 @default.
• W3029262857 hasRelatedWork W2373380562 @default.
• W3029262857 hasRelatedWork W2374628792 @default.
• W3029262857 hasRelatedWork W2376179729 @default.
• W3029262857 hasRelatedWork W2381493761 @default.
• W3029262857 hasRelatedWork W2383310965 @default.
• W3029262857 hasRelatedWork W2389236002 @default.
• W3029262857 hasRelatedWork W2394300898 @default.
• W3029262857 hasRelatedWork W2394366289 @default.
• W3029262857 hasRelatedWork W3028626862 @default.
• W3029262857 hasRelatedWork W3029755223 @default.
• W3029262857 hasRelatedWork W3030780914 @default.
• W3029262857 hasRelatedWork W3030990447 @default.
• W3029262857 hasRelatedWork W3031640257 @default.
• W3029262857 hasRelatedWork W3032490183 @default.
• W3029262857 hasVolume "17" @default.
• W3029262857 isParatext "false" @default.
• W3029262857 isRetracted "false" @default.
• W3029262857 magId "3029262857" @default.
• W3029262857 workType "article" @default.